Results 31 to 40 of about 58,392 (301)

Editorial: Women in radionuclide therapy: 2023 [PDF]

Frontiers in Nuclear Medicine
Egesta Lopci, Federica Matteucci
doaj   +2 more sources

NEMA NU 2-2007 performance characteristics of GE Signa integrated PET/MR for different PET isotopes [PDF]

, 2019
BackgroundFully integrated PET/MR systems are being used frequently in clinical research and routine. National Electrical Manufacturers Association (NEMA) characterization of these systems is generally done with F-18 which is clinically the most relevant
D'Asseler, Yves, De Vasconcelos Caribé, Paulo Rauli Rafeson, Deller, Timothy W, Koole, M., Van Laere, K, Vandenberghe, Stefaan   +5 more
core   +1 more source

Evaluation of myocardial perfusion and function in patients with asymptomatic beta-thalassemia major using myocardial gated single-photon-emission computed tomography

World Journal of Nuclear Medicine, 2021
This study was conducted to evaluate the cardiac perfusion and function of patients with beta-thalassemia major (TM) using 99mTc-MIBI cardiac gated single-photon-emission computed tomography (SPECT) and to compare the obtained indices with ...
Abdolmajid Omrani, Parivash Rahimzadeh, Ali Aba, Esmail Jafari, Abdullatif Amini, Majid Assadi   +5 more
doaj   +1 more source

Radionuclide therapy in the treatment of thyroid malignancy [PDF]

Archive of Oncology, 2003
In this paper we presented the principles of performance of radionuclide therapy, its adverse effect, together with mentioned complications obligation to use it only according to directions and the success of the therapy, which is seen through the length
Malešević Milica Đ.
doaj   +1 more source

New developments in the experimental data for charged particle production of medical radioisotopes [PDF]

, 2015
The goal of the present work is to give a review of developments achieved experimentally in the field of nuclear data for medically important radioisotopes in the last three years.
Ditrói, F., Hermanne, A., Takács, S., Tárkányi, F.   +3 more
core   +2 more sources

PEPTIDE BASED TARGETED RADIONUCLIDE THERAPIES; SCIENCE BEHIND THE SUCCESS.

Journal of Cancer and Allied Specialties, 2016
The radionuclide therapies for solid and liquid malignancies are emerging field nowadays. The targeted radionuclide therapies have been in use since 1945.
Mohammed H Al Rowaily, Daniele Dondi, Marco Chinol, Iqbal Munir, Muaadh AlAsbahi   +4 more
doaj   +1 more source

Radiolabeled nanomaterial for cancer diagnostics and therapeutics: principles and concepts

Cancer Nanotechnology, 2023
In the last three decades, radiopharmaceuticals have proven their effectiveness for cancer diagnosis and therapy. In parallel, the advances in nanotechnology have fueled a plethora of applications in biology and medicine.
Muskan Goel, Yuri Mackeyev, Sunil Krishnan   +2 more
doaj   +1 more source

Continuing Nuclear Data Research for Production of Accelerator-Based Novel Radionuclides for Medical Use: A Mini-Review

Frontiers in Physics, 2021
Nuclear data are important for production and medical application of a radionuclide. This brief review concentrates on nuclear reaction cross-section data.
Syed M. Qaim, Mazhar Hussain, Ingo Spahn, Bernd Neumaier   +3 more
doaj   +1 more source

Combination Therapies with PRRT

Pharmaceuticals, 2021
Peptide receptor radionuclide therapy (PRRT) is a successful targeted radionuclide therapy in neuroendocrine tumors (NETs). However, complete responses remain elusive.
Anna Yordanova, Hojjat Ahmadzadehfar
doaj   +1 more source

Issues and solutions in integrated radionuclide diagnosis and treatment [PDF]

Zhenduanxue lilun yu shijian
The integration of radionuclide diagnosis and treatment combines the dual functions of radionuclide imaging and treatment, and has been widely applied in the diagnosis and treatment of various tumors. Significant progress has been made in this field over
HONG Yena, ZHANG Yü, SHI Kuangyu, LI Biao, GUO Rui
doaj   +1 more source